MING-WAI SELIG: Open Payments
NPI 1710562988 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$718 in 26 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $358 · 2025 $718
Food & beverage: $608Education: $109
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 10 | $296 |
| Teva Pharmaceuticals USA, Inc. | 5 | $186 |
| Vanda Pharmaceuticals Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $48 |
| ABBVIE INC. | 2 | $40 |
| Alkermes, Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: COBENFY, FANAPT, ABILIFY ASIMTUFII, AUSTEDO XR, VRAYLAR, UZEDY, ARISTADA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
